Blue Heron Biotech

Blue Heron Biotechnology Inc., a Bothell, Wash.-based provider of gene synthesis services, has raised around $3.68 million in Series D funding, according to a regulatory filing. Shareholders include Crabtree Ventures, Integra Ventures and Invitrogen Corporation. www.blueheronbio.com